We at tiakis develop novel and groundbreaking therapeutic solutions in indications with high unmet medical need. Based on the body’s own protective mechanisms and more than 20 years of clinical research.
Natural protection smart reinvented
Discover the gamechanger in the treatment of pulmonary-arterial hypertension and in the prevention of postoperative inflammatory complications: our investigational medical product Tiprelestat. Read now all you need to know about the pioneering anti-inflammatory and tissue protective drug being developed by tiakis BIOTECH AG.
Fully dedicated to a novel therapy approach
Read all about our goal to shift the paradigm toward a preventive and underlying cause focused approach for patients and why we believe in strong values like:
Located in Kiel. Connected around the world
Find out, why tiakis BIOTECH AG is the next generation preventive therapeutic biotech company and why we are developing our pioneering tissue protective drug Tiprelestat.